Cytokinetics Inc (CYTK)
65.27
+0.93
(+1.45%)
USD |
NASDAQ |
May 03, 16:00
65.33
+0.06
(+0.09%)
After-Hours: 20:00
Cytokinetics Max Drawdown (5Y): 53.24% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 53.24% |
March 31, 2024 | 53.24% |
February 29, 2024 | 53.24% |
January 31, 2024 | 53.24% |
December 31, 2023 | 65.00% |
November 30, 2023 | 65.00% |
October 31, 2023 | 65.00% |
September 30, 2023 | 65.24% |
August 31, 2023 | 65.24% |
July 31, 2023 | 65.24% |
June 30, 2023 | 65.24% |
May 31, 2023 | 65.24% |
April 30, 2023 | 65.24% |
March 31, 2023 | 65.24% |
February 28, 2023 | 65.24% |
January 31, 2023 | 65.24% |
December 31, 2022 | 65.24% |
November 30, 2022 | 65.24% |
October 31, 2022 | 65.24% |
September 30, 2022 | 65.24% |
August 31, 2022 | 65.24% |
July 31, 2022 | 65.24% |
June 30, 2022 | 65.24% |
May 31, 2022 | 65.24% |
April 30, 2022 | 65.24% |
Date | Value |
---|---|
March 31, 2022 | 65.24% |
February 28, 2022 | 65.24% |
January 31, 2022 | 65.24% |
December 31, 2021 | 65.24% |
November 30, 2021 | 65.24% |
October 31, 2021 | 65.24% |
September 30, 2021 | 65.24% |
August 31, 2021 | 65.24% |
July 31, 2021 | 65.24% |
June 30, 2021 | 65.24% |
May 31, 2021 | 65.24% |
April 30, 2021 | 65.24% |
March 31, 2021 | 65.24% |
February 28, 2021 | 65.24% |
January 31, 2021 | 65.24% |
December 31, 2020 | 65.24% |
November 30, 2020 | 65.24% |
October 31, 2020 | 65.24% |
September 30, 2020 | 65.24% |
August 31, 2020 | 65.24% |
July 31, 2020 | 65.24% |
June 30, 2020 | 65.24% |
May 31, 2020 | 65.24% |
April 30, 2020 | 65.81% |
March 31, 2020 | 65.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
53.24%
Minimum
Jan 2024
86.86%
Maximum
May 2019
66.36%
Average
65.24%
Median
May 2020
Max Drawdown (5Y) Benchmarks
Amgen Inc | 24.86% |
Johnson & Johnson | 27.36% |
Eli Lilly and Co | 22.48% |
Viking Therapeutics Inc | 89.26% |
Madrigal Pharmaceuticals Inc | 82.20% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 37.27 |
Beta (5Y) | 0.7233 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 88.35% |
Historical Sharpe Ratio (5Y) | 0.5131 |
Historical Sortino (5Y) | 1.552 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.95% |